Lucia Craxì
Related Authors
Andy Miah
University of Salford
Rakesh Biswas
University Of Kolkata
Soraj Hongladarom
MahaChulalongkornRajavidyalaya University
Samia Hurst
Université de Genève
Eric S . Kim (UBC)
University of British Columbia
Beatrice Jauregui
University of Toronto
Richard Bellamy
University College London
David Seamon
Kansas State University
John Tasioulas
University of Oxford
Giulia Sissa
Ucla
InterestsView All (22)
Uploads
Papers by Lucia Craxì
therapies has been focused on the problem of drug prices and access to
therapies. Nonetheless, the goal of hepatitis C virus eradication set by the
World Health Organization in 2016 is raising new ethical issues, since
governments are faced with a new challenge: reaching through screening,
diagnosis and treatment a large amount of subjects with undiagnosed
hepatitis C infection. National governments, especially high-income
countries with a Welfare State, are compelled to provide access to
therapies, but also to involve those who are still unaware of their disease
status.
Since people cannot be forced but should be guided towards the choice of
screening, diagnosis and treatment, three concepts will be instrumental in
the success of any HCV elimination policy: involvement, communication
and protection of vulnerable individuals.
Given the importance of diagnosis and treatment both in terms of
individual benefit and social benefit, while respecting individual freedom
and autonomy, the government has a moral obligation to try to drive
individuals on the path of therapy. Even if it fails to get a complete success,
the hepatitis C virus eradication campaign will lead to a significant
reduction in the incidence of the disease and it will convey a very important
message: today more than ever public health interventions must be thought
in a global perspective, far beyond the borders of National States.